[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644641":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":13,"locations":10,"responsibleParty":19,"collaborators":23,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":30,"acronym":31,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":10,"maxAge":10,"enrollmentInfo":34,"targetDuration":37,"studyType":38,"phases":10,"briefSummary":39,"conditions":40,"keywords":44,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":10},{"fullName":5,"class":6},"Salzburger Landeskliniken","OTHER",[8,11],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Controls",[14],{"name":15,"role":16,"phone":17,"phoneExt":10,"email":18},"Lorenz Stana-Hackenberg, MD","CONTACT","+4357255-57757","L.stana-hackenberg@salk.at",{"type":20,"investigatorFullName":21,"investigatorTitle":22,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Lorenz Auer-Hackenberg","Principal Investigator",[24],{"name":25,"class":6},"Wroclaw Medical University","100644641","t6a-biomarker-for-detection-of-bacterial-infection-in-newborn-infants-100644641",false,"NCT07670624","T6A Biomarker for Detection of Bacterial Infection in Newborn Infants","T6ASepsis","Inclusion Criteria:\n\n* Newborn infants who require blood testing for screening for bacterial infection OR treating physician suspects bacterial infection in newborn infant\n* Signed informed consent form\n\nExclusion Criteria:\n\n1. Refusal to participate in study or not providing written informed consent by caregivers\u002Fparents\n2. Antibiotic treatment of any kind.","ALL",{"count":35,"type":36},210,"ESTIMATED","1 Week","OBSERVATIONAL","This study aims to assess the efficacy of a new biomarker, N6-threonylcarbamoyladenosine (t6A), for the early diagnosis of Early-Onset Sepsis (EOS) in newborns.",[41,42,43],"Sepsis","Newborn Sepsis","Biomarker Discovery",[45,46,47,48],"t6a","newborn sepsis","infectious disease biomarker","biomarker","NOT_YET_RECRUITING","2026-06-25",{"date":52,"type":53},"2026-06-26","ACTUAL",{"date":55,"type":36},"2026-07-01",{"date":57,"type":36},"2029-01-31",{"name":5,"class":6}]